Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand

Pitisuttithum, Punnee; B. Gilbert, Peter; Gurwith, Marc; L. Heyward, William; Martin, Michael; van Griensven, Fritz; J. Hu, Dale; W. Tappero, Jordan; Choopanya, Kachit; Vaccine Evaluation Group, Bangkok

doi:10.1086/508748

Public

Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand

Published in The Journal of Infectious Diseases • Nov 13, 2006

Authors:

Punnee Pitisuttithum

Peter B. Gilbert

Marc Gurwith

Abstract

BACKGROUND: In Thailand, phase 1/2 trials of monovalent subtype B and bivalent subtype B/E (CRF01_AE) recombinant glycoprotein 120 human immunodeficiency virus type 1 (HIV-1) vaccines were successfully conducted from 1995 to 1998, prompting the first HIV-1 vaccine efficacy trial in Asia. METHODS: Th...

Subject

Medicine

Placebo

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!